The role of allergen-specific immunotherapy in the treatment of canine atopic dermatitis: Part 2

Authors

  • Sarah Warren BVetMed MSc(ClinOnc) CertVD MRCVS

    Regional Veterinary Dermatologist CVS UK, Southern Region
    1. MILDMAY VETERINARY CENTRE, EASTON LANE, WINCHESTER, HAMPSHIRE. SO23 7RU
    Search for more papers by this author

ABSTRACT:

Allergen-specific immunotherapy is considered an effective therapy for the management of canine atopic dermatitis when relevant allergens have been identified through either intradermal or serological testing. It is an extremely safe form of treatment and serious adverse effects are uncommon. Additional anti-inflammatory or symptomatic therapy during the induction phase of immunotherapy is often needed, depending on the severity of clinical signs in the individual. The long-term success of immunotherapy can be measured by the ability to taper or even withdraw these supportive therapies.

Ancillary